RxDoctor Payments Data

Richard Durocher, DPM

Foot Surgery · North Haven, CTNPI 1306820956

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Organogenesis Inc. accounts for 63.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $306 and has fallen 85.8% since, to $43 in 2025. That places this record below the midpoint for foot surgery clinicians in CT, where the typical reported total is $962.

$962in general payments, 2019–2025

Across 22 payments — averaging $43.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$613
  • Osiris Therapeutics Inc.$119
  • Medtronic$72
  • DJO, LLC$57
  • GRT US Holding, Inc.$33
  • Treace Medical Concepts, Inc.$24
  • plus $43 from 2 others

What the payments were for

  • Food & beverage$962100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$962 in reported general payments places this provider in the 50th percentile of 20 foot surgery providers in Connecticut.

See all foot surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$103,713
Medicare patients
235
Services billed
1,642

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav45$402
Clindamycin Hcl12$186
Azithromycin32$144
Ibuprofen12$16

Paid to pharmacies, not to this prescriber.

Other foot surgery in North Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →